Diversion Control Division, US Department of Justice, Drug Enforcement Administration

REGISTRATION > Notice of Registration > Bulk Manufacturers Notice of Registration - 2022

Bulk Manufacturers Notice of Registration - 2022

BULK MANUFACTURERS

Effective November 4, 2019, the Importers and Bulk Manufacturer Notices of Registration (NORs) will no longer be published in the Federal Register.

View previously published Federal Register Notices

File Registrant FR Docket Date
DRG-22-0135 Cambrex High Point, Inc. 87 FR 61365 1/4/2023
DRG-22-0144 Curia Missouri, Inc. 87 FR 61366 1/4/2023
DRG-22-0147 Groff NA Hemplex LLC 87 FR 62117 1/4/2023
DRG-22-0148 Eli-ElSohly Laboratories 87 FR 61364 1/4/2023
DRG-22-0050 Patheon Pharmaceuticals Inc. 87 FR 27185 12/2/2022
DRG-22-0110 Biopharmaceutical Research Company 87 FR 48511 12/2/2022
DRG-22-0117 Purisys, LLC 87 FR 53009 12/2/2022
DRG-22-0074 Royal Emerald Pharmaceuticals 87 FR 31909 12/2/2022
DRG-22-0084 AMPAC Fine Chemicals LLC 87 FR 42502 10/27/2022
DRG-22-0083 AMPAC Fine Chemicals Virginia, LLC 87 FR 45361 10/27/2022
DRG-22-0091 Cambrex Charles City 87 FR 48692 10/27/2022
DRG-22-0134 Cambrex High Point, Inc. 86 FR 42902 10/27/2022
DRG-22-0119 Cerilliant Corporation 87 FR 48502 10/27/2022
DRG-22-0125 Chattem Chemicals 87 FR 48512 10/27/2022
DRG-22-0124 Chemtos, LLC 87 FR 48497 10/27/2022
DRG-22-0115 Experic LLC 87 FR 48509 10/27/2022
DRG-22-0184 Noramco Coventry LLC 86 FR 70148 10/27/2022
DRG-22-0040 Siemens Healthcare Diagnostics, Inc. 87 FR 16497 10/27/2022
DRG-22-0063 Sterling Wisconsin, LLC 87 FR 25304 9/29/2022
DRG-22-0066 Research Triangle Institute 87 FR 25304 9/29/2022
DRG-22-0103 American Radiolabeled Chem 87 FR 39127 9/29/2022
DRG-22-0028 Caligor Coghlan Pharma Services 87 FR 12981 8/30/2022
DRG-22-0034 Scottsdale Research Institute 87 FR 31259 8/30/2022
DRG-22-0077 PCI Synthesis 87 FR 31902 8/30/2022
DRG-22-0031 Sigma Aldrich Research Biochemicals, Inc. 87 FR 33514 8/30/2022
DRG-22-0100 Xcelience 87 FR 42501 8/30/2022
DRG-22-0076 Scottsdale Research Institute 87 FR 31909 8/30/2022
DRG-22-0065 Pisgah Laboratories, Inc. 87 FR 34720 8/30/2022
DRG-22-0047 Stepan Company 87 FR 34719 8/30/2022
DRG-22-0044 SpecGX LLC 87 FR 25299 7/28/2022
DRG-21-0160 Curia Missouri, Inc. 87 FR 1434 7/28/2022
DRG-22-0011 Johnson Matthey Pharmaceutical Materials Inc. 87 FR 10389 6/30/2022
DRG-22-0036 ANI Pharmaecuticals, Inc. 87 FR 14290 6/30/2022
DRG-22-0025 Janssen Pharmaceuticals Inc. 87 FR 14290 6/30/2022
DRG-22-0064 Patheon API Manufacturing, Inc. 87 FR 16498 6/30/2022
DRG-22-0042 Purisys, LLC 87 FR 20464 6/30/2022
DRG-22-0010 IsoSciences, LLC 86 FR 67723 6/3/2022
DRG-22-0022 Siegfried USA, LLC 87 FR 4941 6/3/2022
DRG-22-0037 Scottsdale Research Institute 87 FR 10390 6/3/2022
DRG-21-0183 Nanosyn Inc. 86 FR 60653 6/3/2022
DRG-22-0013 Benuvia Therapeutics Inc. 87 FR 10388 6/3/2022
DRG-22-0018 Synthcon LLC 87 FR 10820 6/3/2022
DRG-22-0030 S&B Pharma LLC 87 FR 10819 6/3/2022
DRG-22-0012 Kinetochem LLC 86 FR 69070 4/29/2022
DRG-17-0108 National Center for Natural Products Research 84 FR 44920 3/31/2022
DRG-21-0179 SpecGX, LLC 86 FR 70866 3/31/2022
DRG-21-0177 Organix Inc. 86 FR 72274 3/31/2022
DRG-21-0151 Eli-Elsholy Laboratories 86 FR 50903 2/28/2022
DRG-21-0146 Cambridge Isotope Laboratories, Inc. 86 FR 53985 2/28/2022
DRG-21-53117 PCI Synthesis 86 FR 53117 2/28/2022
DRG-21-0174 Organic Consultants, LLC
DBA Cascade Chemistry
86 FR 58692 2/28/2022
DRG-21-0142 Chattem Chemicals 86 FR 58691 2/28/2022
DRG-21-0156 Groff NA Hemplex LLC 86 FR 58692 2/28/2022
DRG-21-0171 Novitium Pharma LLC 86 FR 59199 2/28/2022
DRG-22-0002 Noramco 86 FR 66589 2/28/2022
Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility